Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer

Keyphrases

• Overall Survival 100%
• Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 100%
• Dosimetric Predictors 100%
• Heart Dose 100%
• Overall Survival Rate 50%
• Multivariate Analysis 33%
• High Dose 33%
• Chemoradiotherapy 33%
• Clinical Data 33%
• Dosimetric Parameters 33%
• Radiation Therapy Oncology Group 33%
• Cardiac Toxicity 33%
• Lung 16%
• Randomized Trial 16%
• Tumor 16%
• Median Overall Survival 16%
• Single Institution 16%
• Disease-free Survival 16%
• Prescribed Dose 16%
• Radiation Therapy 16%
• Mediastinal Lymph Nodes 16%
• Lymph Node Involvement 16%
• Patient Demographics 16%
• Organs at Risk 16%
• Dosimetry 16%
• Concurrent Chemotherapy 16%
• Treatment Plan 16%
• Common Terminology Criteria for Adverse Events (CTCAE) 16%
• Clinical Parameters 16%
• Lung Structure 16%
• Heart Volume 16%

Medicine and Dentistry

• Lung Cancer 100%
• Overall Survival 100%
• Survival Rate 30%
• Radiation Therapy 30%
• Non-Small Cell Lung Cancer 30%
• Drug Megadose 20%
• Multivariate Analysis 20%
• Oncology 20%
• Chemoradiotherapy 20%
• Cardiotoxicity 20%
• Neoplasm 10%
• Adverse Event 10%
• Arm 10%
• Mediastinal Lymph Node 10%
• Patient Population 10%
• Disease Free Survival 10%
• Lung Volume 10%
• Dosimetry 10%
• Lung Structure 10%
• Clinical Method 10%
• Chemotherapy 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Overall Survival 100%
• Lung Cancer 100%
• Survival Rate 30%
• Chemoradiation Therapy 20%
• Cardiotoxicity 20%
• Neoplasm 10%
• Adverse Event 10%
• Chemotherapy 10%
• Disease Free Survival 10%
• Dosimetry 10%